Friday, February 02, 2024 7:05:24 AM
100 %!!!!!!!!!!!!! The stock would have to rise by 100 % just to reach the cash value of the company (HAI)!!!!!!!!!!!!!!!!
Bullish
Recent ASMB News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/22/2026 08:01:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 11:15:16 AM
- Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 05/22/2026 11:05:00 AM
- Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases • GlobeNewswire Inc. • 05/22/2026 11:00:00 AM
- Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026 • GlobeNewswire Inc. • 05/13/2026 06:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/11/2026 08:02:14 PM
- Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference • GlobeNewswire Inc. • 05/11/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:17:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:12:15 PM
- Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights • GlobeNewswire Inc. • 05/07/2026 08:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:22:19 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 08:12:43 PM
- Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026 • GlobeNewswire Inc. • 04/09/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:25:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:20:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:10:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:32:25 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/30/2026 04:15:19 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/19/2026 09:04:04 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/19/2026 08:52:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:15:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:10:05 PM
- Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights • GlobeNewswire Inc. • 03/19/2026 08:05:00 PM
- Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes • Business Wire • 12/22/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2025 09:17:56 PM
